Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Aug 2026 for Acrivon Therapeutics, Inc., €26k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Peter Blume-Jensen: trading record in brief
One trade, one date: on 25 August 2026, Peter Blume-Jensen disclosed a transaction of €26k in Acrivon Therapeutics, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter Blume-Jensen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 14,036 shares@ US$2.18Common StockSEC144:0000905148-26-003924
1 of 1 declaration
